BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654,751 | -18.2% | 17,349 | -1.2% | 0.26% | -14.7% |
| Q2 2023 | $799,988 | +19.1% | 17,559 | +6.0% | 0.31% | +9.3% |
| Q1 2023 | $671,633 | -23.2% | 16,559 | -3.5% | 0.28% | -26.4% |
| Q4 2022 | $874,594 | -4.7% | 17,159 | +0.6% | 0.38% | -12.0% |
| Q3 2022 | $918,000 | -16.2% | 17,059 | 0.0% | 0.43% | -12.1% |
| Q2 2022 | $1,095,000 | -19.5% | 17,059 | -2.8% | 0.49% | -3.3% |
| Q1 2022 | $1,361,000 | -9.6% | 17,559 | +0.1% | 0.51% | -5.0% |
| Q4 2021 | $1,505,000 | +8.5% | 17,542 | +1.4% | 0.54% | -15.7% |
| Q3 2021 | $1,387,000 | -1.5% | 17,292 | -1.1% | 0.64% | +13.7% |
| Q2 2021 | $1,408,000 | -5.1% | 17,492 | -0.6% | 0.56% | -12.8% |
| Q1 2021 | $1,483,000 | +6.9% | 17,592 | +1.7% | 0.64% | +1.3% |
| Q4 2020 | $1,387,000 | +2.7% | 17,292 | +3.0% | 0.64% | -2.3% |
| Q3 2020 | $1,350,000 | -6.6% | 16,792 | 0.0% | 0.65% | -13.6% |
| Q2 2020 | $1,445,000 | +5.6% | 16,792 | -0.4% | 0.75% | -15.0% |
| Q1 2020 | $1,369,000 | -8.6% | 16,867 | -5.8% | 0.88% | +14.0% |
| Q4 2019 | $1,497,000 | +3.7% | 17,908 | +8.5% | 0.78% | -2.0% |
| Q3 2019 | $1,444,000 | +6.8% | 16,510 | 0.0% | 0.79% | +3.0% |
| Q2 2019 | $1,352,000 | +1.3% | 16,510 | +0.6% | 0.77% | -11.9% |
| Q1 2019 | $1,334,000 | +25.1% | 16,410 | +1.2% | 0.87% | +11.2% |
| Q4 2018 | $1,066,000 | -14.7% | 16,210 | 0.0% | 0.78% | -4.3% |
| Q3 2018 | $1,249,000 | +5.2% | 16,210 | +0.8% | 0.82% | -12.0% |
| Q2 2018 | $1,187,000 | +14.2% | 16,080 | +0.6% | 0.93% | +17.2% |
| Q1 2018 | $1,039,000 | +6.2% | 15,980 | +5.5% | 0.80% | -5.5% |
| Q4 2017 | $978,000 | – | 15,140 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |